Funding: Ancillary Studies to the National Institute of Diabetes and Digestive and Kidney Diseases NIDDK (R01); November 5, 2009

 

Executive Summary

• Purpose. This Funding Opportunity (FOA) encourages Research Project Grant (R01) applications from qualified investigators to conduct ancillary studies to major ongoing clinical research studies, including clinical trials, epidemiological studies and disease databases supported by the National Institute of Diabetes and Digestive and Kidney Diseases.  Major studies include multi-center investigations, national databases and Phase 3 clinical trials.  Examples of NIDDK-supported major clinical research studies eligible for ancillary studies may be found at http://www2.niddk.nih.gov/Research/ClinicalResearch/AncillaryStudies/ .  This FOA also encourages grant applications for ancillary studies utilizing major clinical research studies supported by other Institutes and Centers of the National Institutes of Health, other government agencies and the private sector.  However, the proposed ancillary study must be designed to advance the scientific research mission of the NIDDK by focusing on diseases and areas of interest of the Institute.  The scientific areas funded by the NIDDK may be found at the following website:  http://www2.niddk.nih.gov/Research/.
• Mechanism of Support. This FOA will utilize the NIH Research Project (R01) grant mechanism.
• Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
• Budget and Project Period. Budgets for direct costs of up to $500,000 per year and a project duration of up to five years may be requested.  Applicants who request $500,000 or more direct costs per year must follow the instruction in Section IV.6.
• Application Research Plan Component Length: The R01 application Research Plan component of the PHS398 may not exceed 25 pages, including tables, graphs, figures, diagrams, and charts.
• Eligible Institutions/Organizations. Institutions/organizations listed in Section III, 1.A. are eligible to apply.
• Eligible Project Directors/Principal Investigators (PDs/PIs). Include Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
• Number of PDs/PIs. More than one PD/PI (i.e., multiple PDs/PIs), may be designated on the application.
• Number of Applications. Applicants may submit more than one application, provided that each application is scientifically distinct.
• Resubmissions. Applicants may submit a resubmission application, but such application must include an Introduction addressing the previous peer review critique (Summary Statement). See new NIH policy on resubmission (amended) applications (NOT-OD-09-003, NOT-OD-09-016).
• Renewals. Applicants may submit a renewal application.
• Application Materials. See Section IV.1 for application materials.
• General Information. For general information on SF424 (R&R) Application and Electronic Submission, see these Web sites:
• SF424 (R&R) Application and Electronic Submission Information: http://grants.nih.gov/grants/funding/424/index.htm
• General information on Electronic Submission of Grant Applications: http://era.nih.gov/ElectronicReceipt/
• Hearing Impaired. Telecommunications for the hearing impaired are available at: TTY:  (301) 451-5936

For Further Information:

 

http://grants.nih.gov/grants/guide/pa-files/PAR-09-247.html